Cordyceps Sunshine Biotech Holdings Co., Ltd. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cordyceps Sunshine Biotech Holdings Co., Ltd. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q4 2023.
  • Cordyceps Sunshine Biotech Holdings Co., Ltd. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $234K, a 31.2% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $234K +$55.5K +31.2% Dec 31, 2023 20-F 2024-07-05
Q4 2022 $178K Dec 31, 2022 20-F 2024-07-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.